Investigational Site Number : 3920025

Shibuya-ku, Tokyo 150-8935

0 studies enrolling now · 1 studies all time

What they study most

Chronic Obstructive Pulmonary Disease

Studies at this site

• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed